CHICAGO–(BUSINESS WIRE)–PRESS RELEASE–Cresco Labs, Inc., one of the largest vertically integrated multistate cannabis operators in the United States, has released its financial results for the third quarter and nine months ended Sept. 30, 2018. All financial information presented in this release is in U.S. dollars, unless otherwise noted.
Subsequent to the end of third quarter 2018, the company completed a business combination with Randsburg International Gold Corp. upon which its subordinate voting shares were approved for listing on the Canadian Securities Exchange (CSE) under the symbol “CL.” Cresco’s shares began trading on the CSE on Monday, Dec. 3, 2018. The company is in the process of receiving approval by FINRA to list on the OTC market in the U.S. and is currently trading under the symbol “CRLBF.” Concurrent with its public listing on the CSE, Cresco launched its new investors website at investors.crescolabs.com.
“As one of the early cannabis companies to establish a national geographic footprint with substantial population reach and production capacity, Cresco is leading the way in normalizing and professionalizing our industry,” said Charles Bachtell, co-founder and CEO of Cresco Labs. “As a multi-state operator, we have repeatedly proven our ability to get access to markets, get operational, get product to market and get disproportionate market share. Early on in our formation, we realized that cannabis is a natural fit within consumer-packaged goods–an industry that requires consistency, reliability and availability. We therefore developed a unique and sophisticated ‘house of brands’ that addresses each major market segment and covers all price points. In essence, we developed a disciplined business blueprint that enables our rapid entry into regulated markets, where operator obligations are stringent, where our products can be accessible to customers, and where we can capture leading market share right from the start.
“Through our differentiated business approach,